Caring robots address shortages in aging societies

Aging societies worldwide face rising demand for elder care amid caregiver shortages. In China, robots in care facilities assist with reminders, medication schedules, and vital sign monitoring. In Latin America, including Cuba, adoption of these technologies remains in early stages but shows promise in complementing family care.

In a care facility in China's Jiangsu province, a waist-high white robot glides between rooms, greeting with a cheerful digital face. It reminds caregivers to reposition bedridden residents, prompts medication schedules, and tracks basic vital signs, notifying medical staff of unusual changes in heart rate or breathing.

This innovation addresses a pressing global issue. According to Pension Policy International, in countries like Chile, Brazil, and Argentina, more than 15 percent of the population is aged 65 or older. In Cuba, the FIU Cuban Research Institute projects that by 2050, about 1.4 million Cubans—roughly 40 percent of the older population—will be over 80.

In many Latin American and Chinese societies, elder care relies heavily on families, but smaller household sizes and migration strain these systems. Service robots are drawing attention and investment.

While fully autonomous humanoid robots for cooking and cleaning remain distant, targeted innovations are making impacts. For instance, exoskeletons aid mobility; Wu Liying, a 70-year-old from Hangzhou, said: “I felt the equipment lifted my legs and made walking much easier,” after climbing two floors without rest.

Nursing robots ease tasks like post-bowel movement cleaning. A caregiver in China's Shaanxi province noted: “Before, I spent more than half a day cleaning waste and changing bedding. Now, with nursing robots, I have more time to talk with my older residents.”

In Latin America, Mexico employs robotic devices in private clinics for mobility therapy. In Cuba, universities experiment with small educational and social robots in healthcare. Brazil trials exoskeletons in post-stroke rehabilitation.

Yet, home use is limited by high costs—an exoskeleton runs about $22,000—and real-world challenges like small apartments. Wang Sumei, an associate researcher at the Chinese Academy of Sciences, stressed improving technical expertise and data collection, though expensive.

Experts clarify that care robots do not replace humans but handle repetitive tasks to enable more personalized care. Broader policies, such as health insurance expansion and community services, are vital. In China, the 15th Five-Year Plan starting in 2026 prioritizes elderly care with institutional support.

Relaterade artiklar

Elon Musk announces Optimus robot sales at Davos WEF, with robot demo on screen.
Bild genererad av AI

Tesla ska sälja Optimus humanoide robotar till allmänheten senast slutet av 2027, meddelar Musk i Davos

Rapporterad av AI Bild genererad av AI

Elon Musk meddelade vid Världsekonomiforumet i Davos att Tesla planerar att sälja sina Optimus humanoide robotar till allmänheten senast slutet av 2027, när tillförlitlighet och säkerhet är garanterade. För närvarande utför de grundläggande uppgifter i Kaliforniens fabriker, kommer att utöka träningen till Texas nästa månad och ta sig an industriella, hushålls- och vårdroller, även om experter varnar för tidsramar mitt i konkurrens och tidigare förseningar.

Analysts suggest China’s rapid AI adoption may limit the economic fallout from its rapidly ageing population. As fertility rates fall across Asia, sustaining growth with fewer workers poses a daunting challenge. The region’s deep semiconductor, tech hardware, and machinery ecosystems enable faster and cheaper deployment than other regions.

Rapporterad av AI

Kina stod för nästan 90 procent av de globala försäljningarna av humanoidrobotar 2025, med inhemska bolag som Unitree och Agibot i topp. Amerikanska företag, inklusive Tesla, sålde betydligt färre enheter trots ambitiösa mål. Denna tidiga dominans speglar Kinas strategi inom elfordon, uppbackad av statligt stöd och försörjningskedjor.

Kina har blivit det första landet att godkänna ett hjärnimplantat för kommersiell försäljning för behandling av funktionsnedsättningar. Implantatet, NEO från Neuracle Medical Technology, gör det möjligt för förlamade personer att styra en robothand med hjälp av sina tankar. Detta står i kontrast till de långsammare framstegen i de kliniska prövningarna i USA och Europa.

Rapporterad av AI

Shenzhen-based EngineAI is leveraging Hong Kong as a springboard for global expansion, planning a local listing this year while using its computing power to enter the North American market. The company's robots have been bought by Mideast firms and require cloud-based computing accessible from anywhere.

Denna webbplats använder cookies

Vi använder cookies för analys för att förbättra vår webbplats. Läs vår integritetspolicy för mer information.
Avböj